260 related articles for article (PubMed ID: 16423040)
21. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
Rock KL; Fleischacker C; Gamble S
J Immunol; 1993 Feb; 150(4):1244-52. PubMed ID: 8381832
[TBL] [Abstract][Full Text] [Related]
22. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
Hornung RL; Longo DL; Gowda VL; Kwak LW
Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
[TBL] [Abstract][Full Text] [Related]
23. A recombinant malaria protein that can induce Th1 and CD8+ T cell responses without antibody formation.
Süss G; Pink JR
J Immunol; 1992 Aug; 149(4):1334-9. PubMed ID: 1380040
[TBL] [Abstract][Full Text] [Related]
24. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.
Cho HJ; Takabayashi K; Cheng PM; Nguyen MD; Corr M; Tuck S; Raz E
Nat Biotechnol; 2000 May; 18(5):509-14. PubMed ID: 10802617
[TBL] [Abstract][Full Text] [Related]
25. IL-12-Dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens.
Swiniarski H; Wolf SF; Sturmhoefel K; Peterson RL; Dorner AJ; O'Toole M
Clin Immunol; 2000 Mar; 94(3):200-11. PubMed ID: 10692239
[TBL] [Abstract][Full Text] [Related]
26. Distinct CD4+ T cell helper requirements in Theileria parva-immune and -naive bovine CTL precursors.
Taracha EL; Awino E; McKeever DJ
J Immunol; 1997 Nov; 159(9):4539-45. PubMed ID: 9379055
[TBL] [Abstract][Full Text] [Related]
27. The cellular immunology of bovine paratuberculosis: immunity may be regulated by CD4+ helper and CD8+ immunoregulatory T lymphocytes which down-regulate gamma/delta+ T-cell cytotoxicity.
Chiodini RJ; Davis WC
Microb Pathog; 1993 May; 14(5):355-67. PubMed ID: 8366813
[TBL] [Abstract][Full Text] [Related]
28. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
29. The induction of cytotoxic T cells and tumor regression by soluble antigen formulation.
Hariharan K; Braslawsky G; Black A; Raychaudhuri S; Hanna N
Cancer Res; 1995 Aug; 55(16):3486-9. PubMed ID: 7627951
[TBL] [Abstract][Full Text] [Related]
30. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.
Barratt-Boyes SM; Vlad A; Finn OJ
Clin Cancer Res; 1999 Jul; 5(7):1918-24. PubMed ID: 10430099
[TBL] [Abstract][Full Text] [Related]
31. Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation.
Garcia MR; Graham S; Harris RA; Beverley SM; Kaye PM
Eur J Immunol; 1997 Apr; 27(4):1005-13. PubMed ID: 9130657
[TBL] [Abstract][Full Text] [Related]
32. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
33. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
34. CD4+ helper T cells are required for resistance to a highly metastatic murine tumor.
Schild HJ; Kyewski B; Von Hoegen P; Schirrmacher V
Eur J Immunol; 1987 Dec; 17(12):1863-6. PubMed ID: 2961578
[TBL] [Abstract][Full Text] [Related]
35. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness.
Shrikant P; Mescher MF
J Immunol; 1999 Mar; 162(5):2858-66. PubMed ID: 10072534
[TBL] [Abstract][Full Text] [Related]
36. Collaboration of helper and cytotoxic T lymphocytes.
Stuhler G; Walden P
Eur J Immunol; 1993 Sep; 23(9):2279-86. PubMed ID: 7690327
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis.
Romieu R; Baratin M; Kayibanda M; Guillet JG; Viguier M
Int Immunol; 1998 Sep; 10(9):1273-9. PubMed ID: 9786426
[TBL] [Abstract][Full Text] [Related]
38. Activation and migration of CD8 T cells in the intestinal mucosa.
Kim SK; Reed DS; Heath WR; Carbone F; Lefrançois L
J Immunol; 1997 Nov; 159(9):4295-306. PubMed ID: 9379025
[TBL] [Abstract][Full Text] [Related]
39. Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses.
Vogel K; Kantor J; Wood L; Rivera R; Schlom J
Cell Immunol; 1998 Nov; 190(1):61-7. PubMed ID: 9826447
[TBL] [Abstract][Full Text] [Related]
40. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
Davila E; Celis E
J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
